Actionable gene variants linked to higher mortality in adults
In 490,086 participants, coding variants in actionable genes were linked to higher mortality, with hazard ratios of 1.42 in females and 1.31 in males.
Limit: Promoter variant activity was assessed in laboratory reporter assays, not in participants' tissues
Edited by Boris Djordjevic · AgingResearch.News
In an observational study of 490,086 adults with whole-genome sequencing from the UK Biobank, researchers tracked how actionable genetic variants were linked to all-cause mortality. The team examined harmful coding variants in 81 disease-related genes and mapped variants in promoters, the DNA regions that control gene activity, using lab-based tests to measure their function.
Actionable coding variants appeared in 3.40% of participants and were associated with increased mortality, showing a hazard ratio of 1.42 in females and 1.31 in males. Rare promoter variants across the genes showed no overall association with survival. However, functional promoter variants that lowered the activity of cancer-related genes were linked to elevated mortality, with a hazard ratio of 1.15 in females and 1.12 in males.
Why it matters
Identifying inherited genetic variants linked to shorter lifespan can help clarify how specific genetic risks contribute to age-related diseases such as cancer. The results suggest that examining regulatory switches that control gene activity, rather than protein-coding DNA alone, may help researchers assess genetic influences on survival.
Caveats
Because this was an observational study, it identifies links between these genetic variants and mortality but cannot establish that the variants directly caused deaths. Additionally, the regulatory impact of the promoter variants was assessed using laboratory reporter assays rather than directly within the participants' own tissues.
The paper
State Key Laboratory of Reproductive Medicine
Journal of Medical Genetics, Aug 12, 2026
